Additional Details

  • Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia

    State University of New York at Buffalo Jacobs School of Medicine and Biomedical Sciences
    Buffalo NY. 14203
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Kingston ON. K7M 4E7
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Denver CO. 80206
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Dallas TX. 75254
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Vancouver BC. V5Z 1M9
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Bethlehem PA. 18015
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Oklahoma City OK. 73117
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Boston MA. 02114
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Philadelphia PA. 19104
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Burlington VT. 05401
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    New York NY. 10029
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    El Paso TX. 79902
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Greensboro NC. 27403
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Richmond VA. 23298
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Burlington ON. L7N 3V2
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Sherwood Park AB. T8H 2M7
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Sherbrooke QC. J1H 5N4
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Houston TX. 77030
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Ann Arbor MI. 48109
    View Details
  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Newport Beach CA. 92663
    View Details